Skip to content

Glycaemic Responses to a Food Intake Sequence Intervention in Free-living Elite Female Athletes

Glycaemic Responses to a Food Intake Sequence Intervention Under Free-living Conditions in Elite Female Athletes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07247513
Enrollment
22
Registered
2025-11-25
Start date
2025-11-24
Completion date
2025-11-29
Last updated
2025-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dietary Intervention, Exercise, Glycemic Variability, Healthy, Nutrition, Sleep

Keywords

food order, meal sequence, glycaemia, sport nutrition

Brief summary

The goal of this clinical trial is to investigate the impact of a food intake sequence intervention under free-living conditions on glycaemic responses in elite female athletes. Specifically, the main questions it aims to answer are: 1. Does consuming breakfast in different food intake sequences alter postprandial interstitial glucose responses? 2. Does consuming a pre-exercise meal in different food intake sequences alter interstitial glucose responses during exercise? 3. Does consuming the last meal of the day in different food intake sequences alter nocturnal interstitial glucose responses? To address these questions, researchers will compare eating the dietary sources of rapidly absorbed carbohydrate (CHO) at the end (CHO-last meal pattern) or at the start (CHO-first meal pattern) of standardised mixed meals, at different times of day, in a randomised, counterbalanced, crossover design. Participants will wear a blinded continuous glucose monitor (CGM) for 6 consecutive days during a training camp. Throughout the study, they will be provided with buffet meals, at the same time and location each day. Dietary intake will be ad libitum, except for breakfast and supper, for which participants will select a preferred composition (ingredients, preparation methods, portion sizes) to replicate across study days. In all ad libitum meals (i.e., lunch, snacks, and dinner), they will be asked to maintain their assigned food intake sequence. * On day 1, athletes will eat freely. An educational session on the study protocol and food sequence manipulation will be delivered, and informed consent, questionnaires, screening assessments, and CGM fitting will be completed. Data collected by the CGM during the first 24 hours will be disregarded due to sensor stabilisation. Hence, this period will serve for familiarisation only. * On days 2 and 3, one group will eat the last meal of the day (i.e., supper) in a CHO-last meal pattern, while the other will follow a CHO-first meal pattern; on days 3 and 4 one group will eat breakfast in a CHO-last meal pattern while the other will follow a CHO-first meal pattern. * On days 4 and 5 (supper) and 5 and 6 (breakfast), participants in each group will adhere to the alternate condition. Concurrent data on potential confounding factors (e.g., dietary intake, physical activity, internal and external load during training sessions/competition, sleep quantity and quality, menstrual cycle phase/status) will be collected. Due to the short camp duration, implementing a one-day washout period will not be feasible. Therefore, repeated measurements over two consecutive days per condition will be obtained to minimise carryover effects of the food intake sequence from prior meals on end-of-intervention data (the final 24 hours per condition), and to assess intraindividual consistency of outcomes at matched-times and standardised settings. Glycaemic responses will be compared within-participant between food intake sequences using linear mixed models with random intercepts, to account for repeated measures, interindividual variability, and potential missing data.

Interventions

Participants will consume the main dietary sources of protein, fat, fibre and/or polyphenols before the main dietary sources of simple carbohydrate in the standardised test-meals (breakfast and supper) and will be encouraged to maintain this food intake sequence in the remaining meals of the day. Participants will be instructed to consume lunch and dinner within 30 min, and breakfast and supper within 15 min at a comfortable pace, without intervals between the carbohydrate and non-carbohydrate-rich meal components.

Participants will consume the main dietary sources of protein, fat, fibre and/or polyphenols after the main dietary sources of simple carbohydrate in the standardised test-meals (breakfast and supper) and will be encouraged to maintain this food intake sequence in the remaining meals of the day. Participants will be instructed to consume lunch and dinner within 30 min, and breakfast and supper within 15 min at a comfortable pace, without intervals between the carbohydrate and non-carbohydrate-rich meal components.

Sponsors

Federação Portuguesa de Futebol
CollaboratorUNKNOWN
Fundação para a Ciência e a Tecnologia
CollaboratorOTHER
Universidade do Porto
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Masking description

It is not possible to blind participants or researchers envolved in data collection to the intervention assigned in each period due to the nature of the intervention and comparator (food intake sequence of the same elements within a meal). However, both will be blinded to CGM data throughout the study.

Intervention model description

This trial is designed as a randomised, counterbalanced, crossover, open label, superiority trial with two groups. Block randomization will be performed by an external researcher with a 1:1 allocation ratio, and allocation concealment will be ensured through the use of sequentially numbered, opaque, sealed envelopes.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 64 Years
Healthy volunteers
Yes

Inclusion criteria

* Adult (18-64 years old) * Women * Elite athletes (meeting training and performance caliber criteria ≥Tier 4; McKay et al., 2022) * Healthy (meeting the

Exclusion criteria

for medical conditions) * Normal glucose tolerant according to the latest review standards of the American Diabetes Association (ElSayed et al., 2024): HbA1c \<5.7%, fasting plasma glucose \<5.6 mmol/L (100 mg/dL), or 2-h plasma glucose \<7.8 mmol/L (140 mg/dL) during a 75-g OGTT * Able and willing to provide informed consent and safely comply with study procedures

Design outcomes

Primary

MeasureTime frameDescription
Incremental interstitial glucose peak after a standardised test meal0-120 minutes following a standardised test mealDifference between CHO-last and CHO-first meal patterns in the incremental interstitial glucose peak (mmol/L) adjusted for baseline, following standardised breakfasts (independent of and coinciding with subsequent exercise) and the end-of-intervention (days 3 and 5) standardised supper, assessed using a blinded continuous glucose monitoring system (Freestyle Libre Pro IQ).

Secondary

MeasureTime frameDescription
Within-day standard deviation of interstitial glucose24 hoursDifference between CHO-last and CHO-first meal patterns in the 24-hour standard deviation (SD) of interstitial glucose concentrations during the end-of-intervention monitoring period (days 3 and 5), assessed using a blinded continuous glucose monitoring system (Freestyle Libre Pro IQ sensor).
Within-day coefficient of variation of interstitial glucose24 hoursDifference between CHO-last and CHO-first meal patterns in the 24-hour coefficient of variation (%) of interstitial glucose concentrations during the end-of-intervention monitoring period (days 3 and 5), assessed using a blinded continuous glucose monitoring system (Freestyle Libre Pro IQ sensor).
Mean amplitude of glycaemic excursions (MAGE)24 hoursDifference between CHO-last and CHO-first meal patterns in the mean amplitude of glycaemic excursions (MAGE) during the end-of-intervention monitoring period (days 3 and 5), assessed using a blinded continuous glucose monitoring system (Freestyle Libre Pro IQ sensor).
Large amplitude of glycaemic excursions (LAGE)24 hoursDifference between CHO-last and CHO-first meal patterns in the large amplitude of glycaemic excursions (LAGE) during the end-of-intervention monitoring period (days 3 and 5), assessed using a blinded continuous glucose monitoring system (Freestyle Libre Pro IQ sensor).
Within-day time out of interstitial glucose range24 hoursDifference between CHO-last and CHO-first meal patterns in the time spent \>7.8 mmol/L and \<3.9 mmol/L (%) over 24 hours during the end-of-intervention monitoring period (days 3 and 5), assessed using a blinded continuous glucose monitoring system (Freestyle Libre Pro IQ sensor).
Interstitial glucose concentrations during specific activities24 hoursDifference between CHO-last and CHO-first meal patterns in the mean interstitial glucose concentrations (mmol/L) across 15-minute averages and adjusted for baseline where relevant, during the following periods: after standardised breakfasts (independent of and coinciding with exercise); after the end-of-intervention (days 3 and 5) standardised supper, during exercise not coinciding with postprandial periods, during evening sleep, and during daytime rest, assessed using a blinded continuous glucose monitoring system (Freestyle Libre Pro IQ).
Incremental area under the interstitial glucose curve after a standardised test meal0-120 minutes following a standardised test mealDifference between CHO-last and CHO-first meal patterns in the incremental area under the interstitial glucose curve (mmol/L x min) adjusted for baseline, following standardised breakfasts (independent of and coinciding with subsequent exercise) and the end-of-intervention (days 3 and 5) standardised supper, assessed using a blinded continuous glucose monitoring system (Freestyle Libre Pro IQ).
Time-to-peak interstitial glucose after a standardised test meal0-120 minutes following a standardised test mealDifference between CHO-last and CHO-first meal patterns in the time-to-peak interstitial glucose (minutes), following standardised breakfasts (independent of and coinciding with subsequent exercise) and the end-of-intervention (days 3 and 5) standardised supper, assessed using a blinded continuous glucose monitoring system (Freestyle Libre Pro IQ).
Time out of interstitial glucose range after a standardised test meal0-180 minutes following a standardised test mealDifference between CHO-last and CHO-first meal patterns in the time spent \>7.8 mmol/L and time \<3.9 mmol/L (%), following standardised breakfasts (independent of and coinciding with subsequent exercise) and the end-of-intervention (days 3 and 5) standardised supper, assessed using a blinded continuous glucose monitoring system (Freestyle Libre Pro IQ).
Interstitial glucose dip after a standardised test meal0-180 minutes following a standardised test mealDifference between CHO-last and CHO-first meal patterns in the 2-3-hour interstitial glucose dip (mmol/L), following standardised breakfasts not coinciding with subsequent exercise, and the end-of-intervention (days 3 and 5) standardised supper, assessed using a blinded continuous glucose monitoring system (Freestyle Libre Pro IQ).
Between-day glycaemic variability24 hoursDifference between CHO-last and CHO-first meal patterns in the mean of daily differences (MODD) of interstitial glucose responses at matched clock times, assessed using a blinded continuous glucose monitoring system (Freestyle Libre Pro IQ).

Countries

Portugal

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026